Sign Up to like & get
recommendations!
0
Published in 2018 at "Hepatology"
DOI: 10.1002/hep.30356
Abstract: 443 placebo is observed in patient-reported outcomes or subjective measures; the effect of placebo on objective biomarkers or hard outcomes such as mortality are likely minimal.(2) Hence, in this study, when evaluating mortality as primary…
read more here.
Keywords:
reported outcomes;
indirect comparisons;
effect;
effect estimates ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Actas dermo-sifiliograficas"
DOI: 10.1016/j.ad.2020.10.003
Abstract: Meta-analysis offers a way to assess the clinical efficacy of a treatment by combining the results of randomized clinical trials while maintaining randomization; the combined effects, with their confidence intervals, can be represented with a…
read more here.
Keywords:
indirect comparisons;
biologic treatments;
efficacy;
meta ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.13997
Abstract: Generic products can be regarded as therapeutically equivalent and switchable with the reference product. However, switchability between generics is unknown, as direct comparisons between generics are not performed. The aim of this study was to…
read more here.
Keywords:
generic clopidogrel;
indirect comparisons;
bioequivalence generic;
clopidogrel products ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "European Journal of Haematology"
DOI: 10.1111/ejh.13873
Abstract: In chronic lymphocytic leukemia, growing evidence has accumulated about long‐term outcomes of first‐line treatments. Our objective was to perform indirect comparisons across first‐line treatments.
read more here.
Keywords:
indirect comparisons;
long term;
chronic lymphocytic;
lymphocytic leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359211018018
Abstract: Background: The addition of PD-L1 inhibitors to platinum-based chemotherapy (CT) has newly received United States Food and Drug Administration (FDA) approval in extensive stage-small cell lung cancer (ES-SCLC). PD-1 agents similarly improved survival rates, even…
read more here.
Keywords:
indirect comparisons;
landmark survival;
subgroups landmark;
among subgroups ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Epidemiology"
DOI: 10.2147/clep.s352045
Abstract: Introduction Advanced hepatocellular carcinoma (HCC) represents a major public health threat. Several emerging combination therapies have shown promising results for the first-line treatment of advanced HCC. The present study compared the efficacy of atezolizumab plus…
read more here.
Keywords:
advanced hepatocellular;
hepatocellular carcinoma;
indirect comparisons;
comparative effectiveness ... See more keywords